Thymidine kinase 2 deficiency-induced mtDNA depletion in mouse liver leads to defect β-oxidation
- PMID: 23505564
- PMCID: PMC3591375
- DOI: 10.1371/journal.pone.0058843
Thymidine kinase 2 deficiency-induced mtDNA depletion in mouse liver leads to defect β-oxidation
Abstract
Thymidine kinase 2 (TK2) deficiency in humans causes mitochondrial DNA (mtDNA) depletion syndrome. To study the molecular mechanisms underlying the disease and search for treatment options, we previously generated and described a TK2 deficient mouse strain (TK2(-/-)) that progressively loses its mtDNA. The TK2(-/-) mouse model displays symptoms similar to humans harboring TK2 deficient infantile fatal encephalomyopathy. Here, we have studied the TK2(-/-) mouse model to clarify the pathological role of progressive mtDNA depletion in liver for the severe outcome of TK2 deficiency. We observed that a gradual depletion of mtDNA in the liver of the TK2(-/-) mice was accompanied by increasingly hypertrophic mitochondria and accumulation of fat vesicles in the liver cells. The levels of cholesterol and nonesterified fatty acids were elevated and there was accumulation of long chain acylcarnitines in plasma of the TK2(-/-) mice. In mice with hepatic mtDNA levels below 20%, the blood sugar and the ketone levels dropped. These mice also exhibited reduced mitochondrial β-oxidation due to decreased transport of long chain acylcarnitines into the mitochondria. The gradual loss of mtDNA in the liver of the TK2(-/-) mice causes impaired mitochondrial function that leads to defect β-oxidation and, as a result, insufficient production of ketone bodies and glucose. This study provides insight into the mechanism of encephalomyopathy caused by TK2 deficiency-induced mtDNA depletion that may be used to explore novel therapeutic strategies.
Conflict of interest statement
Figures





Similar articles
-
Long term survival and abnormal liver fat accumulation in mice with specific thymidine kinase 2 deficiency in liver tissue.PLoS One. 2023 Oct 5;18(10):e0285242. doi: 10.1371/journal.pone.0285242. eCollection 2023. PLoS One. 2023. PMID: 37796969 Free PMC article.
-
Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice.EBioMedicine. 2019 Aug;46:342-355. doi: 10.1016/j.ebiom.2019.07.042. Epub 2019 Jul 24. EBioMedicine. 2019. PMID: 31351931 Free PMC article.
-
Thymidine kinase 2 deficiency-induced mitochondrial DNA depletion causes abnormal development of adipose tissues and adipokine levels in mice.PLoS One. 2011;6(12):e29691. doi: 10.1371/journal.pone.0029691. Epub 2011 Dec 27. PLoS One. 2011. PMID: 22216345 Free PMC article.
-
Thymidine kinase 2 enzyme kinetics elucidate the mechanism of thymidine-induced mitochondrial DNA depletion.Biochemistry. 2014 Oct 7;53(39):6142-50. doi: 10.1021/bi5006877. Epub 2014 Sep 23. Biochemistry. 2014. PMID: 25215937 Review.
-
Deoxyribonucleoside kinases in mitochondrial DNA depletion.Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1205-15. doi: 10.1081/NCN-200027480. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15571232 Review.
Cited by
-
Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.Mitochondrion. 2015 May;22:96-118. doi: 10.1016/j.mito.2015.01.008. Epub 2015 Jan 29. Mitochondrion. 2015. PMID: 25640959 Free PMC article. Review.
-
Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease.Front Endocrinol (Lausanne). 2018 Apr 18;9:177. doi: 10.3389/fendo.2018.00177. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29720963 Free PMC article. Review.
-
IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer's disease mouse model.Elife. 2022 Aug 30;11:e75889. doi: 10.7554/eLife.75889. Elife. 2022. PMID: 36040311 Free PMC article.
-
Long term survival and abnormal liver fat accumulation in mice with specific thymidine kinase 2 deficiency in liver tissue.PLoS One. 2023 Oct 5;18(10):e0285242. doi: 10.1371/journal.pone.0285242. eCollection 2023. PLoS One. 2023. PMID: 37796969 Free PMC article.
-
Long term expression of Drosophila melanogaster nucleoside kinase in thymidine kinase 2-deficient mice with no lethal effects caused by nucleotide pool imbalances.J Biol Chem. 2014 Nov 21;289(47):32835-44. doi: 10.1074/jbc.M114.588921. Epub 2014 Oct 8. J Biol Chem. 2014. PMID: 25296759 Free PMC article.
References
-
- DiMauro S, Moraes CT (1993) Mitochondrial Encephalomyopathies. Arch Neurol 50: 1197–1208. - PubMed
-
- McFarland R, Taylor RW, Turnbull DM (2002) The neurology of mitochondrial DNA disease. Lancet Neurol 1: 343–351. - PubMed
-
- Saada A, Shaag A, Mandel H, Nevo Y, Eriksson et al (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29: 342–344. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases